Skip to content

Clinical trials

Overweight trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Overweight Country / region: United States Clear all

1,457 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20016
20026
20033
200411
200521
200635
200742
200855
200946
201043
201135
201255
201337
201456
201548
201646
201760
201875
201970
202053
202176
202260
202392
202499
2025143
2026175

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed948
Recruiting212
Active, not recruiting119
Terminated56
Unknown status41
Not yet recruiting40
Withdrawn25
Enrolling by invitation15
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company78
Novo Nordisk A/S56
University of California, San Diego31
University of North Carolina, Chapel Hill30
University of Colorado, Denver29
Massachusetts General Hospital25
USDA Grand Forks Human Nutrition Research Center25
Johns Hopkins University24
The Miriam Hospital24
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)21

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Overweight1,457
Obesity1,295
Weight Loss221
Diabetes Mellitus, Type 2117
Diabetes Mellitus79
Body Weight73
Hypertension67
Insulin Resistance67
Prediabetic State63
Metabolic Syndrome46

Trials

Showing 1 to 25 of 1,457. Each trial links to its page on Pharma Observatory.

1,357 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.